drugset / Trial / NCT06327152

Caffeine Use in the Management of Preterm Infants

NCT06327152

Phase 2 Active not recruiting 80 enrolled University of California, Irvine
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to assess whether extending the duration of caffeine therapy will help preterm infants achieve full oral feeding faster.

Timeline

Start
2024-02-22
Primary completion
2026-12
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Caffeine Small molecule 10 mg/kg Oral
Comparator Caffeine Small molecule 15 mg/kg Oral

Indications